** Shares of Evolent Health EVH.N down 4.7% post-market to $8.60 as healthcare tech firm looks to raise capital
** Arlington, Virginia-based EVH announces private offering of $140 mln convertible bonds (CBs) due 2031
** It plans to use $100 mln of net proceeds to repurchase a portion of its 1.50% CBs due 2025
** Co also intends to use $40 mln to repurchase its stock concurrently with pricing of the offering in privately negotiated transactions
** With ~117.5 mln shares outstanding, EVH has roughly $1.1 bln market cap, per LSEG data
** EVH shares on Mon closed down 3% at $9.02, down ~20% YTD
** Of 14 analysts covering EVH, recommendation breakdown is 13 "strong buy" or "buy" and 1 "hold"; median PT is $16 - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。